ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.69194
-0.24%
Brent Oil
81.955
0.79%
Bitcoin
68,925.97
1.47%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Immatics NV (IMTX)

  7. Immatics NV (IMTX) Noticias

IMTX

Immatics NV (IMTX)

Immatics NV
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:IMTX
FechaHoraFuenteTítuloSímboloCompañía
14/05/202406:00GlobeNewswire Inc.Immatics Announces First Quarter 2024 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
21/03/202406:00GlobeNewswire Inc.Immatics Announces Full Year 2023 Financial Results and Corporate UpdateNASDAQ:IMTXImmatics NV
22/01/202411:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
19/01/202407:58Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMTXImmatics NV
17/01/202419:30GlobeNewswire Inc.Immatics Announces Pricing of $175 Million Public OfferingNASDAQ:IMTXImmatics NV
17/01/202415:01GlobeNewswire Inc.Immatics Announces Proposed Public OfferingNASDAQ:IMTXImmatics NV
16/01/202403:06PR Newswire (US)DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed FinancingNASDAQ:IMTXImmatics NV
30/11/202303:00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEONASDAQ:IMTXImmatics NV
14/11/202306:00GlobeNewswire Inc.Immatics Announces Third Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
08/11/202306:00GlobeNewswire Inc.Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 TrialNASDAQ:IMTXImmatics NV
24/10/202306:00GlobeNewswire Inc.Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T MonotherapyNASDAQ:IMTXImmatics NV
13/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMTXImmatics NV
13/09/202316:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IMTXImmatics NV
11/09/202306:00GlobeNewswire Inc.Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNASDAQ:IMTXImmatics NV
25/08/202315:11Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:IMTXImmatics NV
17/08/202306:00GlobeNewswire Inc.Immatics Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
10/08/202306:00GlobeNewswire Inc.Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid TumorsNASDAQ:IMTXImmatics NV
24/07/202306:00GlobeNewswire Inc.Immatics Announces $35 Million Equity Investment from Bristol Myers SquibbNASDAQ:IMTXImmatics NV
20/06/202315:21Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMTXImmatics NV
16/05/202306:00GlobeNewswire Inc.Immatics Announces First Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
02/05/202306:00GlobeNewswire Inc.Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine® IMA203 TCR-T Targeting PRAMENASDAQ:IMTXImmatics NV
01/05/202306:00GlobeNewswire Inc.Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic CollaborationNASDAQ:IMTXImmatics NV
22/03/202305:57Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:IMTXImmatics NV
21/03/202306:31GlobeNewswire Inc.Immatics Announces Full Year 2022 Financial Results and Corporate UpdateNASDAQ:IMTXImmatics NV
14/02/202316:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMTXImmatics NV
07/02/202305:07Edgar (US Regulatory)Schedule 13g
(sc 13g)		NASDAQ:IMTXImmatics NV
20/11/202222:15TipRanksSVB Securities Sticks to Their Buy Rating for Immatics (IMTX)NASDAQ:IMTXImmatics NV
17/11/202217:15TipRanksChardan Capital Sticks to Their Buy Rating for Immatics (IMTX)NASDAQ:IMTXImmatics NV
17/11/202206:00GlobeNewswire Inc.Immatics Announces Third Quarter 2022 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
11/10/202205:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:IMTXImmatics NV
 Showing the most relevant articles for your search:NASDAQ:IMTX

Su Consulta Reciente

NASDAQ
BREZ
Breeze Holdings Acquisit...
DGFX
MENGOUSDT
Flamengo Fan Token
LSE
AP61
Barclays 29
NYSE
DMYI.U
dMY Technology Group Inc...
LSE
0O7K
Lena Lighting
COIN
COFUSD
COIN
ARTICUST
ARTIC
NASDAQ
CRNC
Cerence
COIN
LUSDUSD
LUSD Stablecoin
LSE
ZQ57
Hsbc Bk. 28
LSE
74LG
Hsbc Bk.26
LSE
38ML
Bazalgette 48
COIN
STEPUST
Step Finance
EU
H960T
H960T
LSE
82NN
Hsbc Bk. 24
ASX
CCPKOC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados